ExoBow: A transgenic strategy to study CD63 exosomes in vivo

Bárbara Adem, Nuno Bastos, Carolina F. Ruivo, Patrícia F Vieira, Barbara Seidler, José Carlos Machado, Dieter Saur, Dawen Cai, Sónia A. MelobioRxiv 2021 · DOI

TL;DR

Researchers have developed a novel transgenic mouse model, "ExoBow," that allows for the real-time tracking of CD63-positive exosomes within living organisms. This innovative tool overcomes previous limitations in studying exosome biodistribution and intercellular communication, paving the way for a deeper understanding of their roles in health and disease, particularly in complex systems like cancer.

What Problem Does This Paper Address?

Exosomes, tiny vesicles released by cells, are crucial players in intercellular communication, influencing a wide range of biological processes from maintaining homeostasis to driving diseases like cancer. However, understanding how these exosomes function in vivo has been a significant challenge. Current methods for tracking exosomes in living systems are limited, making it difficult to determine where they go, which cells they interact with, and how they contribute to complex biological networks. This lack of effective tools hinders our ability to fully grasp the biology of exosomes and translate in vitro findings into clinically relevant applications. The authors aim to bridge this gap by creating a sophisticated mouse model that enables the visualization and tracing of endogenously produced exosomes.

Methods

The core innovation is the development of the ExoBow transgene. This genetic construct is designed for conditional and inducible expression. It involves inserting a modified CD63 gene (a well-known exosomal marker) fused with up to four different fluorescent reporter proteins (mCherry, phiYFP, eGFP, and mTFP) into the ROSA26 locus of mice.

Key features of the methodology include:

  • Conditional Expression: A stop cassette flanked by Flp recombinase recognition sites (Frt sites) is placed upstream of the CD63-XFP fusion gene. This prevents transcription until Flp recombinase is present, allowing for tissue-specific or inducible activation.
  • Multireporter System: Following the CD63 gene, four fluorescent reporters are present, each flanked by distinct and incompatible Lox recombination sites (LoxN, Lox2272, Lox5171). When Cre recombinase is introduced, it stochastically excises one of these Lox sites, leading to the expression of a specific fluorescent protein fused to CD63. This allows for the "color-coding" of exosomes originating from different cells or at different times.
  • Monocolor and Multireporter Models: By crossing the ExoBow line with different recombinase systems (Flp-only or Flp and Cre), researchers can generate either a monocolor model (e.g., CD63-mCherry) or a multireporter model (ExoBow).
  • Pancreas-Specific Models: The authors demonstrate the utility of ExoBow by crossing it with pancreas-specific Cre and Flp driver lines (Pdx1-Cre and Pdx1-Flp) to create pancreas-specific reporters (Panc-ExoBow).
  • Cancer Models: They further integrated ExoBow into existing genetically engineered mouse models of pancreatic ductal adenocarcinoma (PDAC) to study exosome communication in the tumor microenvironment.
  • Standard Techniques: The paper also details standard molecular biology techniques such as cell culture, transfection, exosome isolation (using ultracentrifugation and sucrose gradients), western blotting, immunofluorescence microscopy, flow cytometry, and PCR-based genotyping.

Datasets

Not discussed in the paper. The study focuses on the development and application of a genetically engineered mouse model.

Key Insights and Ideas

  • Unlocking In Vivo Exosome Tracking: The ExoBow system provides an unprecedented ability to visualize and track endogenous exosomes directly within living animals, overcoming the limitations of in vitro studies or the use of exogenous labels.
  • Cellular "Color-Coding" of Exosomes: The multireporter system allows for the differentiation of exosomes based on their cell of origin or the timing of their release, enabling the mapping of complex communication networks.
  • Tracing Intra- and Inter-cellular Communication: ExoBow can distinguish between exosomes released by the same cell type within a tissue (intra-cellular) and those traveling between different cell types or organs (inter-cellular).
  • Pancreas as a Model System: The successful application of ExoBow in the pancreas, both in normal physiological conditions and in the context of PDAC, highlights its versatility and potential for studying various tissues and diseases.
  • Exosome Uptake in Tumor Microenvironment: The study demonstrates that cancer-derived CD63+ exosomes can be taken up by cancer-associated fibroblasts (CAFs) in PDAC models, providing direct visual evidence of exosome-mediated communication in the tumor niche.

Key Results

  • Successful Transgene Development: The ExoBow transgene was successfully engineered and integrated into the mouse genome, demonstrating efficient recombination mediated by both Flp and Cre recombinases in embryonic stem cells.
  • Color-Coded Exosome Secretion: BxPC-3 cells transfected with CD63-XFP constructs were shown to secrete color-coded exosomes, confirming the functionality of the reporter system.
  • Pancreas-Specific Reporter: The Panc-ExoBow mouse model exhibited efficient recombination and CD63-mCherry expression specifically in the pancreas, with detected fluorescence in both exocrine and endocrine cells.
  • Exosome Production in PDAC Models: In PDAC models (KPF and KPC), the ExoBow transgene allowed for the visualization of CD63-mCherry positive cancer cells and their secreted exosomes.
  • Exosome Entry into CAFs: In PDAC tumors, CD63-mCherry positive exosomes were observed to enter CAFs, providing direct evidence of intercellular communication within the tumor microenvironment.

Limitations and Future Work

  • Potential Overexpression Effects: The authors acknowledge that overexpressing tetraspanins (like CD63) might have unintended effects on exosome production, release, distribution, and function, which cannot be overlooked.
  • Heterogeneity of Extracellular Vesicles: The study notes that cells produce heterogeneous populations of extracellular vesicles, and current models are limited to studying one population based on the chosen tetraspanin marker (CD63 in this case). The development of a truly ubiquitous marker is still lacking.
  • Imaging Challenges with Homozygous Models: While homozygous ExoBow mice could potentially express up to 10 colors, this could present significant imaging challenges.
  • Future Directions: The authors suggest that the ExoBow system's plasticity, allowing for both monocolor and multireporter applications, will be invaluable for addressing complex biological questions related to intra- and inter-organ/cell-type communication mediated by CD63+ exosomes. Further studies can leverage this tool to explore exosome roles in various physiological and pathological contexts.

Summary updated

Abstract

ABSTRACT Exosomes are described as central players in a myriad of biological processes. However, the available methodologies to study their function in complex biological systems in vivo are still very limited. The biodistribution of endogenously produced exosomes, the ability to trace their spontaneous flow in order to identify the cell types they interact with, remains a major challenge. New tools to identify comprehensive networks of communication established by exosomes originated in distinct cell types in vivo , are fundamental for a better understanding of their biology. Here, we describe the development of a genetically engineered mouse model that allows the expression of the mouse CD63 exosomal marker fused with one (monocolor) or up to four fluorescent proteins (multireporter), the ExoBow. The genetic design of the ExoBow transgene allows the conditional expression of the reporters in any tissue/cell-type in an inducible or non-inducible fashion. In addition, communication mediated by CD63 positive (CD63 + ) exosomes can be identified amongst the same tissue/cell types using the multireporter version of the model, in order to map intra-organ/tissue communication. We demonstrate the applicability of the ExoBow transgene in normal physiological conditions and in the context of cancer, using pancreas as a working model. The ExoBow comprises a unique strategy to identify intra- and inter-organ/cell-type communication mediated by CD63 + exosomes. We believe this tool will contribute for a better understanding of the complex interactions occurring in vivo that underly the biology of exosomes in health and disease.
BibTeX
@misc{adem2021exobow,
  author = {Bárbara Adem and Nuno Bastos and Carolina F. Ruivo and Patrícia F Vieira and Barbara Seidler and José Carlos Machado and Dieter Saur and Dawen Cai and Sónia A. Melo},
  title = {{ExoBow: A transgenic strategy to study CD63 exosomes <i>in vivo</i>}},
  year = {2021},
  doi = {10.1101/2021.03.10.434407},
  howpublished = {bioRxiv},
}
Figure